Could hyperbaric oxygen be an effective therapy option for pathological scars? A systematic review and meta-analysis

References

• Feng Y, Sun ZL, Liu SY, et al. Direct and indirect roles of macrophages in hypertrophic scar formation. Front Physiol. 2019;10:1101.
   PubMed Web of Science ®Google Scholar
• Holl EK, Bond JE, Selim MA, et al. The nucleic acid scavenger polyamidoamine third-generation dendrimer inhibits fibroblast activation and granulation tissue contraction. Plast Reconstr Surg. 2014;134(3):420e–433e.
   PubMed Web of Science ®Google Scholar
• Hall C, Hardin C, Corkins CJ, et al. Pathophysiologic mechanisms and current treatments for cutaneous sequelae of burn wounds. Compr Physiol. 2017;8(1):371–405.
   PubMed Web of Science ®Google Scholar
• Li Q, Zhang C, Fu X. Will stem cells bring hope to pathological skin scar treatment? Cytotherapy. 2016;18(8):943–956.
   PubMed Web of Science ®Google Scholar
• Wang ZC, Zhao WY, Cao Y, et al. The roles of inflammation in keloid and hypertrophic scars. Front Immunol. 2020;11:603187.
   PubMed Web of Science ®Google Scholar
• Zhang T, Wang XF, Wang ZC, et al. Current potential therapeutic strategies targeting the TGF-β/smad signaling pathway to attenuate keloid and hypertrophic scar formation. Biomed Pharmacother. 2020;129:110287.
   PubMed Web of Science ®Google Scholar
• Tran B, Wu JJ, Ratner D, et al. Topical scar treatment products for wounds: a systematic review. Dermatol Surg. 2020;46(12):1564–1571.
   PubMed Web of Science ®Google Scholar
• Grabowski G, Pacana MJ, Chen E. Keloid and hypertrophic scar formation, prevention, and management: Standard review of abnormal scarring in orthopaedic surgery. J Am Acad Orthop Surg. 2020;28(10):e408–e14.
   PubMed Web of Science ®Google Scholar
• Sharp PA, Pan B, Yakuboff KP, et al. Development of a best evidence statement for the use of pressure therapy for management of hypertrophic scarring. J Burn Care Res. 2016;37(4):255–264.
   PubMed Web of Science ®Google Scholar
• Ojeh N, Bharatha A, Gaur U, et al. Keloids: current and emerging therapies. Scars Burn Heal. 2020;6:2059513120940499.
   Google Scholar
• Fernández-Crehuet P, Fernández-Crehuet JL, Benitez-Camacho F. Successful cosmetic outcome of earlobe keloid after surgical excision and topical imiquimod 5. Dermatol Ther. 2020;33(6):e13815.
   PubMed Web of Science ®Google Scholar
• Kranke P, Bennett MH, Martyn-St James M, et al. Hyperbaric oxygen therapy for chronic wounds. Cochrane Database Syst Rev. 2015;2015(6):Cd004123.
   PubMedGoogle Scholar
• Selçuk CT, Ozalp B, Durgun M, et al. The effect of hyperbaric oxygen treatment on the healing of burn wounds in nicotinized and nonnicotinized rats. J Burn Care Res. 2013;34(4):e237–e243.
   PubMed Web of Science ®Google Scholar
• Bennett MH, Feldmeier J, Hampson NB, et al. Hyperbaric oxygen therapy for late radiation tissue injury. Cochrane Database Syst Rev. 2016;4(4):CD005005.
   PubMedGoogle Scholar
• Ren J, Liu S, Wan J, et al. Effect of hyperbaric oxygen on the process of hypertrophic scar formation in rabbit ears. J Cosmet Dermatol. 2018;17(6):1240–1249.
   PubMed Web of Science ®Google Scholar
• Higgins JP, Altman DG, Gøtzsche PC, et al. The cochrane collaboration's tool for assessing risk of bias in randomised trials. BMJ. 2011;343:d5928.
   PubMed Web of Science ®Google Scholar
• Guo DZ, Shi W, Zhang DX, et al. Effect and safety of radiotherapy post operation combined with hyperbaric oxygen in treatment of keloid. J Chinese J Med Aesthetics Cosmetol. 2019;25(03):234–237.
   Google Scholar
• Chang C, White C, Katz A, et al. Management of ischemic tissues and skin flaps in re-operative and complex hypospadias repair using vasodilators and hyperbaric oxygen. J Pediatr Urol. 2020;16(5):672.e1–e8.
   PubMed Web of Science ®Google Scholar
• Chen K-L, Wu C-J, Tseng W-S, et al. Improvement of satisfaction in burn patients receiving adjuvant hyperbaric oxygen therapy. Formos J Surg. 2018;51(5):184–191.
   Web of Science ®Google Scholar
• Song KX, Liu S, Zhang MZ, et al. Hyperbaric oxygen therapy improves the effect of keloid surgery and radiotherapy by reducing the recurrence rate. J Zhejiang Univ Sci B. 2018;19(11):853–862.
   PubMed Web of Science ®Google Scholar
• Liang Y, Zhou R, Fu X, et al. HOXA5 counteracts the function of pathological scar-derived fibroblasts by partially activating p53 signaling. Cell Death Dis. 2021;12(1):40.
   PubMed Web of Science ®Google Scholar
• Kal HB, Veen RE, Jürgenliemk-Schulz IM. Dose-effect relationships for recurrence of keloid and pterygium after surgery and radiotherapy. Int J Radiat Oncol Biol Phys. 2009;74(1):245–251.
   PubMed Web of Science ®Google Scholar
• Ince B, Ismayilzade M, Arslan A, et al. Evaluation of the effect of hyperbaric oxygen therapy on hypertrophic scar formation in a rabbit ear model: an experimental study. Dermatol Ther. 2020;33(6):e14146.
   PubMed Web of Science ®Google Scholar
• Türkaslan T, Yogun N, Cimşit M, et al. Is HBOT treatment effective in recovering zone of stasis? An experimental immunohistochemical study. Burns. 2010;36(4):539–544.
   PubMed Web of Science ®Google Scholar
• Romero-Valdovinos M, Cárdenas-Mejía A, Gutiérrez-Gómez C, et al. Keloid skin scars: the influence of hyperbaric oxygenation on fibroblast growth and on the expression of messenger RNA for insulin like growth factor and for transforming growth factor. In Vitro Cell Dev Biol Anim. 2011;47(7):421–424.
   PubMed Web of Science ®Google Scholar
• Takeyama N, Sakai H, Ohtake H, et al. Effects of hyperbaric oxygen on gene expressions of procollagen, matrix metalloproteinase and tissue inhibitor of metalloproteinase in injured medial collateral ligament and anterior cruciate ligament. Knee Surg Sports Traumatol Arthrosc. 2007;15(4):443–452.
   PubMed Web of Science ®Google Scholar
• Boersema GSA, Wu Z, Kroese LF, et al. Hyperbaric oxygen therapy improves colorectal anastomotic healing. Int J Colorectal Dis. 2016;31(5):1031–1038.
   PubMed Web of Science ®Google Scholar
• Hao Y, Dong X, Zhang M, et al. Effects of hyperbaric oxygen therapy on the expression levels of the inflammatory factors interleukin-12p40, macrophage inflammatory protein-1β, platelet-derived growth factor-BB, and interleukin-1 receptor antagonist in keloids. Medicine. 2020;99(16):e19857.
   PubMed Web of Science ®Google Scholar
• Niu X, Lin X, Chen X, et al. Long-wave ultraviolet ray promotes inflammation in keloid-derived fibroblasts by activating P38-NFκB1 signaling pathway. J Burn Care Res. 2020;41(6):1231–1239.
   PubMed Web of Science ®Google Scholar
• Coentro JQ, Pugliese E, Hanley G, et al. Current and upcoming therapies to modulate skin scarring and fibrosis. Adv Drug Deliv Rev. 2019;146:37–59.
   PubMed Web of Science ®Google Scholar
• Zhang M, Liu S, Guan E, et al. Hyperbaric oxygen therapy can ameliorate the EMT phenomenon in keloid tissue. Medicine. 2018;97(29):e11529.
   PubMed Web of Science ®Google Scholar
• Kang Y, Roh MR, Rajadurai S, et al. Hypoxia and HIF-1α regulate collagen production in keloids. J Invest Dermatol. 2020;140(11):2157–2165.
   PubMed Web of Science ®Google Scholar
• Lei R, Li J, Liu F, et al. HIF-1α promotes the keloid development through the activation of TGF-β/SMAD and TLR4/MyD88/NF-κB pathways. Cell Cycle. 2019;18(23):3239–3250.
   PubMed Web of Science ®Google Scholar
• Wang X, Zhang Y, Jiang BH, et al. Study on the role of hsa-miR-31-5p in hypertrophic scar formation and the mechanism. Exp Cell Res. 2017;361(2):201–209.
   PubMed Web of Science ®Google Scholar
• Steinbrech DS, Mehrara BJ, Chau D, et al. Hypoxia upregulates VEGF production in keloid fibroblasts. Annal Plastic Surg. 1999;42(5):514–519. Discussion 9–20.
   PubMed Web of Science ®Google Scholar